Both in Biotechnology
Denali Therapeutics vs Iovance Biotherapeutics
Over the past year DNLI returned +38.3% and IOVA returned +337.2%; their daily moves had a correlation of 0.26.
DNLI +38.3% IOVA +337.2%Growth of $1, one year, split-adjusted
| Metric | DNLI | IOVA |
|---|---|---|
| Price | $19.45 | $8.83 |
| Market cap | $3.11B | $4.00B |
| Today | +3.13% | +10.10% |
| 1 month | −2.3% | −37.6% |
| 6 months | +2.8% | +121.9% |
| Year to date | +17.8% | +223.4% |
| 1 year | +19.5% | +348.2% |
| Revenue growth (YoY) | — | +65.7% |
| Gross margin | 97.4% | 56.1% |
| Net margin | −3539.2% | −47.6% |
| P/E (TTM) | — | — |
| Price / sales | 862.7× | 12.3× |
| Net cash | $705.0M | $297.7M |
| Dividend yield | — | — |
| Volatility (60d) | 38.0% | 130.2% |
| Short % of float | 11.6% | 15.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).